Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly's price for Portrazza way too high for its limited benefit in lung cancer, doctors say
Lilly's price for Portrazza way too high for its limited benefit in lung cancer, doctors say
Lilly's price for Portrazza way too high for its limited benefit in lung cancer, doctors say
Submitted by
admin
on December 14, 2015 - 4:15pm
Source:
Fierce Pharma
News Tags:
drug pricing
Portrazza
Eli Lilly
non-small cell lung cancer
Headline:
Lilly's price for Portrazza way too high for its limited benefit in lung cancer, doctors say
Do Not Allow Advertisers to Use My Personal information
